Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_017771.5(PXK):c.1100T>C(p.Val367Ala) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
PXK (HGNC:23326): (PX domain containing serine/threonine kinase like) This gene encodes a phox (PX) domain-containing protein which may be involved in synaptic transmission and the ligand-induced internalization and degradation of epidermal growth factors. Variations in this gene may be associated with susceptibility to systemic lupus erythematosus (SLE). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.1100T>C (p.V367A) alteration is located in exon 11 (coding exon 11) of the PXK gene. This alteration results from a T to C substitution at nucleotide position 1100, causing the valine (V) at amino acid position 367 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Loss of glycosylation at P363 (P = 0.0284);Loss of glycosylation at P363 (P = 0.0284);Loss of glycosylation at P363 (P = 0.0284);.;.;Loss of glycosylation at P363 (P = 0.0284);.;.;